Vargeese Chandra

Officer at WVE

Sold, on record
$880k
Dollars the filings state
Form 4 sales
12
Latest Feb 9, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • WVEWave Life Sciences Ltd.Officer

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale WVEPlan not stated
    Feb 19, 2019 2019

    Sold 2,055 shares at $36.84 ($76k)

    Vargeese Chandra, Senior VP, Drug Discovery

    Sold 7.5% of holdings ($1M position)25,245 shares left1x usual sizeFiling

  2. 2 Form 4 sale WVEPlan not stated
    Dec 3, 2019 +287 days

    Sold 6,000 shares at $35.00 ($210k)

    Vargeese Chandra, Senior VP, Drug Discovery

    Sold 13% of holdings ($1.6M position)40,245 shares left3x usual sizeFiling

  3. 3 Form 4 sale WVEPlan not stated
    Feb 18, 2020 +77 days

    Sold 3,188 shares at $7.85 ($25k)

    Vargeese Chandra, Senior VP, Drug Discovery

    Sold 7.9% of holdings ($316k position)37,057 shares left1.1x usual sizeFiling

  4. 4 Form 4 sale WVEPlan not stated
    Feb 16, 2021 +364 days

    Sold 3,145 shares at $10.57 ($33k)

    Vargeese Chandra, Chief Technology Officer

    Sold 3.6% of holdings ($936k position)85,412 shares left1x usual sizeFiling

  5. 5 Form 4 sale WVEPlan not stated
    Feb 16, 2022 +365 days

    Sold 10,603 shares at $2.32 ($25k)

    Vargeese Chandra, Chief Technology Officer

    Sold 12% of holdings ($205k position)77,809 shares leftFiling

  6. 6 Form 4 sale WVEPlan not stated
    May 5, 2022 +78 days

    Sold 16,714 shares at $1.72 ($29k)

    Vargeese Chandra, Officer

    Sold 13.1% of holdings ($220k position)111,095 shares leftFiling

  7. 7 Form 4 sale WVEPlan not stated
    Feb 16, 2023 +287 days

    Sold 10,249 shares at $4.03 ($41k)

    Vargeese Chandra, Officer

    Sold 8.8% of holdings ($471k position)106,624 shares left1x usual sizeFiling

  8. 8 Form 4 sale WVENo plan
    Feb 9, 2026 +1089 days

    Sold 3,228 shares at $13.45 ($43k)

    Vargeese Chandra, Officer

    No 10b5-1 planSold 0.8% of holdings ($5.5M position)408,246 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (12)

Form 144 notices and Form 4 sales by Vargeese Chandra
Source
Feb 9, 2026Feb 11, 2026WVEOfficerForm 4 sale3,228$43k0.8%No planSEC
Feb 16, 2023Feb 17, 2023WVEOfficerForm 4 sale10,249$41k8.8%Plan not statedSEC
May 5, 2022May 6, 2022WVEOfficerForm 4 sale16,714$29k13.1%Plan not statedSEC
Feb 16, 2022Feb 18, 2022WVEChief Technology OfficerForm 4 sale10,603$25k12.0%Plan not statedSEC
Feb 16, 2021Feb 18, 2021WVEChief Technology OfficerForm 4 sale3,145$33k3.6%Plan not statedSEC
Feb 18, 2020Feb 20, 2020WVESenior VP, Drug DiscoveryForm 4 sale3,188$25k7.9%Plan not statedSEC
Dec 3, 2019Dec 5, 2019WVESenior VP, Drug DiscoveryForm 4 sale6,000$210k13.0%Plan not statedSEC
Feb 19, 2019Feb 21, 2019WVESenior VP, Drug DiscoveryForm 4 sale2,055$76k7.5%Plan not statedSEC
Sep 24, 2018Sep 26, 2018WVESenior VP, Drug DiscoveryForm 4 sale3,000$165k9.9%Plan not statedSEC
Feb 15, 2018Feb 20, 2018WVEOfficerForm 4 sale2,000$100k6.8%Plan not statedSEC
Jan 23, 2018Jan 25, 2018WVEOfficerForm 4 sale2,000$80k16.9%Plan not statedSEC
Nov 22, 2017Nov 22, 2017WVEOfficerForm 4 sale1,500$53k100.0%UnusualSEC